Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-31

FDA Approved: PHENTERMINE HYDROCHLORIDE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)

View source ↗

Summary

The FDA approved a supplemental application for phentermine hydrochloride from Sunrise Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine hydrochloride (Phentermine hydrochloride)

Snippet

SUPPL AP for PHENTERMINE HYDROCHLORIDE (PHENTERMINE HYDROCHLORIDE)